BIOMIMETIX JV LLC
Potent Therapeutics For Serious Diseases
Englewood, United States · Founded 2015 · $5.0M raised
- Headquarters
- Englewood, Colorado
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- biomimetixpharma.com
- Total Funding
- $5.0M
- Last Round
- $602K GrantDec 2022
- Rounds
- 4
About
BioMimetix JV, LLC is a clinical-stage biotechnology company developing metalloporphyrins, a novel class of redox-active compounds that enhance tumor killing while protecting healthy tissue during chemoradiation. Its lead compound BMX-001 has received FDA Breakthrough Therapy designation and is preparing for a Phase 3 pivotal trial in high-grade glioma.
Summary
BIOMIMETIX JV LLC is a Biotech company based in Englewood, United States, founded in 2015. It has raised $5.0M in total across 4 rounds, most recently a $602K Grant round in Dec 2022. Investors include National Institutes of Health.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2022
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.